Description

Cocarboxilaza (cocarboxylase) hydrochloride lyophilisate for solution for injections 50 mg. vial №1 0

Ingredients:

Each vial contains 50 mg of Cocarboxilaza (cocarboxylase) hydrochloride lyophilisate.

Dosage:

The usual dosage is 50 mg injected intramuscularly or intravenously once daily.

Indications:

Cocarboxilaza is indicated for the treatment of various metabolic disorders, including thiamine deficiency. It plays a crucial role in carbohydrate metabolism and helps in the production of energy.

Contraindications:

Do not use Cocarboxilaza in patients with known hypersensitivity to the drug. Caution is advised in patients with renal impairment.

Directions:

Follow the instructions of your healthcare provider for the correct administration of Cocarboxilaza. It is usually administered by a healthcare professional in a clinical setting.

Scientific Evidence:

Studies have shown the efficacy of Cocarboxilaza in treating thiamine deficiency and improving metabolic functions. Research published in the Journal of Clinical Medicine supports the use of cocarboxylase in enhancing energy production in patients with metabolic disorders.

Additional Information:

Cocarboxilaza is well-tolerated, with minimal side effects reported. It is considered a safe and effective treatment option for metabolic disorders. Consult your healthcare provider for more information.

Pharmacological Effects: Cocarboxilaza acts as a coenzyme in various metabolic pathways, facilitating the conversion of carbohydrates into energy. It plays a vital role in the Krebs cycle, promoting ATP production and supporting cellular functions.

Clinical Trials: Clinical trials have demonstrated the efficacy of Cocarboxilaza in improving symptoms associated with thiamine deficiency, such as fatigue and weakness. Patients receiving Cocarboxilaza showed significant improvements in energy levels and overall well-being compared to placebo groups.